Apogee Therapeutics, Inc. · NASDAQ:APGE
Henderson Jane sold 2,000 Apogee Therapeutics, Inc. shares (Form 4)
Traded May 1, 2026 · Filed May 4, 2026
On May 1, 2026, Henderson Jane (Chief Financial Officer) sold 2,000 Apogee Therapeutics, Inc. shares at an average US$82.04 for US$164K under a trading plan, leaving 173,371 shares. Filed May 4, 2026 (Form 4).
- Sold
- 2,000 shares
- Price
- US$82.04 average (US$81.02 to US$83.16)
- Value
- US$164K
- Holding after
- 173,371 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Sale | 811 | US$81.02 | 174,560 | Direct |
| May 1, 2026 | Common Stock | Sale | 900 | US$82.60 | 173,660 | Direct |
| May 1, 2026 | Common Stock | Sale | 289 | US$83.16 | 173,371 | Direct |
Source
Related
- Apogee Therapeutics, Inc.
- Henderson Jane
- Apogee Therapeutics, Inc. shareholders
- Form 4 · Henderson Jane · Sep 3, 2026
- Form 4 · Henderson Jane · Jul 24, 2026
- Form 4 · Henderson Jane · Apr 17, 2026
- Form 4 · Henderson Jane · Apr 3, 2026
- Schedule 13D/A · Venrock Healthcare Capital Partners III, L.P. · Sep 8, 2026
- Form 4 · Fairmount Funds Management LLC · Sep 3, 2026
- Form 4 · McKenna Mark C. · Sep 3, 2026
- Form 4 · Jones William A Jr · Sep 3, 2026
- Form 4 · Dambkowski Carl · Sep 3, 2026